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ABSTRACT
Infection and inflammation are able to induce diet-independent Na+-accumulation without commensu-
rate water retention in afflicted tissues, which favors the pro-inflammatory activation of mouse macro-
phages and augments their antibacterial and antiparasitic activity. While Na+-boosted host defense
against the protozoan parasite Leishmania major is mediated by increased expression of the leishmani-
cidal NOS2 (nitric oxide synthase 2, inducible), the molecular mechanisms underpinning this enhanced
antibacterial defense of mouse macrophages with high Na+ (HS) exposure are unknown. Here, we
provide evidence that HS-increased antibacterial activity against E. coli was neither dependent on
NOS2 nor on the phagocyte oxidase. In contrast, HS-augmented antibacterial defense hinged on
HIF1A (hypoxia inducible factor 1, alpha subunit)-dependent increased autophagy, and NFAT5 (nuclear
factor of activated T cells 5)-dependent targeting of intracellular E. coli to acidic autolysosomal compart-
ments. Overall, these findings suggest that the autolysosomal compartment is a novel target of Na+-
modulated cell autonomous innate immunity.
Abbreviations: ACT: actins; AKT: AKT serine/threonine kinase 1; ATG2A: autophagy related 2A; ATG4C:
autophagy related 4C, cysteine peptidase; ATG7: autophagy related 7; ATG12: autophagy related 12; BECN1:
beclin 1; BMDM: bone marrow-derived macrophages; BNIP3: BCL2/adenovirus E1B interacting protein 3;
CFU: colony forming units; CM-H2DCFDA: 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate,
acetyl ester; CTSB: cathepsin B; CYBB: cytochrome b-245 beta chain; DAPI: 4,6-diamidino-2-phenylindole;
DMOG: dimethyloxallyl glycine; DPI: diphenyleneiodonium chloride; E. coli: Escherichia coli; FDR: false
discovery rate; GFP: green fluorescent protein; GSEA: gene set enrichment analysis; GO: gene ontology;
HIF1A: hypoxia inducible factor 1, alpha subunit; HUGO: humangenome organization; HS: high salt (+ 40mM
of NaCl to standard cell culture conditions); HSP90: heat shock 90 kDa proteins; LDH: lactate dehydrogenase;
LPS: lipopolysaccharide; Lyz2/LysM: lysozyme 2; NFAT5/TonEBP: nuclear factor of activated T cells 5; MΦ:
macrophages; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MFI: mean fluorescence
intensity; MIC: minimum inhibitory concentration; MOI: multiplicity of infection; MTOR: mechanistic target
of rapamycin kinase; NaCl: sodium chloride; NES: normalized enrichment score; n.s.: not significant; NO: nitric
oxide; NOS2/iNOS: nitric oxide synthase 2, inducible; NS: normal salt; PCR: polymerase chain reaction; PGK1:
phosphoglycerate kinase 1; PHOX: phagocyte oxidase; RFP: red fluorescent protein; RNA: ribonucleic acid;
ROS: reactive oxygen species; sCFP3A: super cyan fluorescent protein 3A; SBFI: sodium-binding benzofuran
isophthalate; SLC2A1/GLUT1: solute carrier family 2 (facilitated glucose transporter), member 1; SQSTM1/
p62: sequestosome 1; ULK1: unc-51 like kinase 1; v-ATPase: vacuolar-type H+-ATPase; WT: wild type
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Introduction
Cutaneous infections can induce a diet-independent accu-
mulation of Na+ into the skin without commensurate
water retention. This results in an increase in effective
osmolyte load approximately 40 mM higher than that in
plasma or standard cell culture conditions [1]. Mimicking
these conditions, by stimulating macrophages (MΦ)
in vitro in the presence of high NaCl concentrations
(additional 40 mM NaCl on top of standard cell culture
media NaCl concentrations; total [Na+] of approximately
180 mM), resulted in increased inflammatory MФ
responses, including NOS2-dependent production of anti-
microbial NO (nitric oxide) [1–4]. These changes were
dependent on activation of the osmoprotective transcrip-
tion factor NFAT5/TonEBP. The transcription factor
NFAT5 plays a key role in the adaption of various cells
to increases in extracellular Na+ levels [5–7]. Moreover,
NFAT5 plays also an important role in MΦ immunobiol-
ogy under standard cell culture conditions [8–11]. High
salt conditions increased NFAT5 levels in MΦ, and
resulted in improved antiparasitic control of Leishmania
major infection both in vitro and in vivo [1]. These
findings established a role for local tissue Na+ levels as
a protective element to fight infections [12,13]. Of note,
enhanced antimicrobial MΦ activity with high Na+ is not
restrained to anti-parasitic defenses but is also operative
against E. coli [1,14]. Moreover, there is evidence that
increased extracellular Na+ helps in antigen degradation
[15] and fighting viral infections [16,17]. In addition,
elevated Na+ levels prime malignant cells for apoptosis
[18,19] and augment the cytotoxic potential of death
receptors in cancer cells [20]. However, the mechanism
underlying enhanced antibacterial activity in MΦ is
unclear.
Recently, Kitada et al demonstrated that, upon a high salt
diet, mice generate urea which serves as an alternative osmolyte
that facilitates Na+ excretion while avoiding water loss. This
metabolic osmoprotective response includes increased autop-
hagic activity in muscles [21]. Autophagy is a cell-intrinsic
catabolic mechanism that is essential in the recycling of
damaged or aged organelles and proteins, and cellular adaption
to starvation and various extracellular stress signals [22].
Moreover, autophagy is involved in rapid, cell-autonomous
antimicrobial innate immune response triggered by various
pathogens [23,24]. It is known that autophagy is regulated by
cell starvation and environmental signals including the class
I phosphoinositide 3-kinase (PI3K)-AKT/PKB, MTOR
(mechanistic target of rapamycin kinase) and HIF1A (hypoxia
inducible factor 1, alpha subunit) [25,26].
Here, we show that elevated extracellular Na+ levels
increase the induction of autophagy and target E. coli to acidic
autolysosomal compartments, which ultimately favors
enhanced antibacterial MΦ activity. We find that the tran-
scription factors HIF1A and NFAT5 govern these activities
cooperatively. These results demonstrate that Na+ is
a regulator of autophagy and thereby facilitates increased cell-
intrinsic antibacterial MΦ function.
Results
Elevated extracellular Na+ boosts antibacterial activity of
macrophages
To assess the impact of increased [Na+] on the antibacterial func-
tion ofMΦ, we infectedRAW264.7MΦ andmouse bonemarrow-
derived MΦ (BMDM) with E. coli and subjected them to genta-
micin protection assays. MΦwere first exposed to E. coli for 2 h in
normal/isotonic media (normal salt, NS) to exclude any potential
effect of high Na+ on phagocytosis, before switching MΦ cultures
to high Na+ conditions (additional 40 mM NaCl on top of stan-
dard cell culture NaCl concentrations; high salt, HS). After 24 h of
infection, E. coli-recovery was determined. In line with previous
observations [1,14] we confirmed that increased Na+ reduced
bacterial load both in BMDM and RAW264.7 MΦ (Figure 1(a)).
HS neither affected the viability of the infected MΦ (Figure 1(b))
nor impaired the growth of E. coli cultured alone (Figure 1(c)).
Moreover, increases in Na+ did not decrease the minimum inhi-
bitory concentration (MIC) of gentamicin directed against the
E. coli strain used in our study (Figure 1(d)) and a reference
E. coli strain (Fig. S1). This demonstrates that elevated Na+ levels
do not increase the susceptibility of E. coli towards gentamicin.
Analysis of phagocytic capacity of MΦ using Latex beads revealed
that Na+ levels neither affected the adsorption of the beads to MΦ
(4°C) nor influenced the internalization of the beads (37°C; Figure
1(e)). Therefore, we tested whether simultaneous MΦ infection
and incubation in HS-conditions reduced bacterial recovery.
Again, HS reduced intracellular bacterial load (Figure 1(f)).
Taken together, these findings demonstrate that HS enhances cell-
intrinsic antibacterial activity of MΦ.
Mannitol-induced osmotic stress does not induce Na+
entry and impairs antibacterial activity
Elevation of extracellular Na+ resulted in rapid influx of Na+ in
infected cells (Figure 2(a)) while elevating tonicity with mannitol
(a nonionic osmolyte that increases tonicity but does not penetrate
the cell membrane [27]) did not result in increased cytosolic Na+
levels (Figure 2(b)). Conforming to earlier studies in proximal
tubular cells [28], increases in intracellular Na+ upon HS condi-
tionswere paralleled by reduced intracellular Ca2+ contents inMΦ
(Figure S2(a)). Activation ofMΦ underNS conditions is known to
trigger outward K+ currents [29–32]. However, HS conditions did
not impact on the gradual decrease of intracellular K+ levels of
E. coli-infected MΦ (Figure S2(b)). These findings demonstrate
that increased extracellular Na+ impacts on the electrolyte balance
of MΦ, while the nonionic osmolyte mannitol does not affect
intracellular Na+ levels. We also tested whether mannitol
increases MΦ antibacterial activity. In contrast to high salt condi-
tions, mannitol impaired antibacterial MΦ activity (Figure 2(c)).
Increased antibacterial activity of macrophages under
high Na+ conditions is not mediated by enhanced NOS2
or PHOX activity
We previously demonstrated that high salt enhanced MФ clear-
ance of the intracellular parasite Leishmania major by increasing
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the production of leishmanicidal NO [1]. Therefore, we wanted
to determine whether the HS-increased antibacterial effects
observed here similarly hinge on enhanced NO and/or ROS
(reactive oxygen species) production. In line with a recent pub-
lication [33], HS treatment decreased ROS production in E. coli-
infected MΦ (Figure 3(a)). In MΦ from mice deficient for the
Cybb (cytochrome b 245 subunit of phagocyte NADPH oxidase
[cybb-/-]), HS treatment similarly increased antibacterial activity
(Figure 3(b)). As described earlier [1], HS increased E. coli-
triggered NO production at a MOI (multiplicity of infection)
of 10 (Figure 3(c)). This was paralleled by enhanced bacterial
elimination (Figure 3(d)). However, at higher MOIs of 50 and
100, exposure to high extracellular [Na+] did not further increase
NO production (Figure 3(c)), but still facilitated enhanced E. coli
elimination (Figure 3(d)). Together, this suggests that the HS-
increased antibacterial MΦ activity is not associated to NO
Figure 1. HS boosts antibacterial activity of MΦ against E. coli. (a) BMDM or RAW264.7 MΦ were infected with E. coli (MOI 100) under normal salt conditions (NS) and
subjected to gentamicin protection assays (upper panel). Where indicated, cells were exposed to high salt conditions (HS; +40 mM NaCl) 2 h after infection. Confocal
images: sfGFP-E. coli, green; Phalloidin, red; DAPI (DNA), blue. Scale bar: 10 µm. Intracellular E. coli load, colony-forming units (CFU) relative to mean CFU under NS
conditions (means ± s.e.m; nBMDM = 23–24; nRAW264.7 = 10–11; Student’s t test ± Welch correction, * p < 0.05). (b) Cells treated as in (a) or with 20% DMSO (dimethyl
sulfoxide). Relative LDH (Lactate dehydrogenase)-release was quantified (means ± s.e.m; n = 9–12; Kruskal-Wallis test with Dunn’s multiple comparison tests. *
p < 0.05). (c) E. coli were grown in the absence of host cells in cell culture media under NS and HS conditions. At the indicated time points, CFU were determined
(means ± s.e.m; n = 4–6). (d) Minimal inhibitory concentration of gentamicin against E. coli HB101 under NS and HS conditions (means ± s.e.m; n = 4). (e) BMDM
were exposed to Latex beads at 37°C or at 4°C for ½ h under NS or HS and subjected to flow cytometry. Mean fluorescence intensities (MFI) were recorded (means ±
s.e.m; n = 8; Student’s t test; * p < 0.05). (f) As in (a), but directly after infection MΦ were incubated under NS or HS for 2 h (upper panel). Confocal images: sfGFP-
E. coli, green; Phalloidin, red; DAPI (DNA), blue. Scale bar: 10 µm. Intracellular E. coli load, CFU relative to mean CFU under NS conditions (means ± s.e.m; nBMDM = 18;
nRAW264.7 = 29–31; Student’s t test ± Welch correction, * p < 0.05).
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production. In line with this, inhibition of NOS2 (and PHOX
[phagocyte oxidase]) activity using DPI (diphenyleneiodonium
chloride) impaired NO release of infected MΦ (Figure 3(c)), but
this did not interfere with HS-mediated antibacterial activity, as
HS treatment still enhanced MΦ bacterial elimination (Figure 3
(d)). Altogether, these findings indicate that Na+ increased MΦ
antibacterial activity does not require PHOX- or NOS2-activity.
High Na+ conditions increase autophagy of E.
coli-infected macrophages
Recently, we demonstrated that high dietary salt intake induces
autophagy in muscle cells [21]. Given that autophagy is linked
with cell-autonomous elimination of bacteria [23,24], and that
increased Na+ induces autophagy in MΦ [34], we hypothesized
that HS might mediate increased MΦ antibacterial defense via
elevated autophagy. To test this, we performed gene set enrich-
ment analysis (GSEA) with an Illumina Bead chip array dataset of
BMDM exposed to high Na+ levels published by Ip et al [2], and
our own Agilent microarray dataset obtained from
RAW246.7 MΦ stimulated with LPS (lipopolysaccharide) in the
absence or presence of HS. By comparing these datasets with the
list of genes annotated by the HUGO (Human Genome
Organization) as ‘Autophagy related’ or in the ‘Kegg Autophagy
pathway’, we found significant positive enrichment for both gene
lists in the data from Ip et al (Kegg –NES [normalized enrichment
score] = 2.086, FDR [false discovery rate] q value = 0.00480,
HUGO – NES = 1.657, FDR q value = 0.0235; HUGO GSEA in
Figure 4(a)), and the HUGO gene set in our own microarray
(HUGO – NES = 2.323, FDR q value = 0.0085, Kegg – NES –
1.243, FDR q value = 0.1991; Figure 4(b)), indicating an increased
expression of genes involved in autophagy in both datasets.
Differentially expressed genes from our microarray dataset within
the HUGO ‘Autophagy related’ gene set are presented in Figure 4
(c). Various transcripts involved autophagy initiation (such as
Ulk1 [unc-51 like kinase 1]), vesicle nucleation (such as Becn1
[beclin 1]), vesicle elongation (such as Atg12 [autophagy
related 12]) and membrane retrieval (such as Atg2a [autophagy
related 2a]) were altered in HS conditions (Figure 4(c)). Several
genes were validated by quantitative real-time PCR experiments
with E. coli-infected RAW246.7 MΦ, which revealed that the
expression of Ulk1, Atg2a and Atg4c (autophagy related 4C,
cysteine peptidase) is indeed increased in HS conditions, while
the expression of Becn1 and Atg7 (autophagy related 7) was not
affected (Figure 4(d)). BMDM were generated from mice that
constitutively express GFP (green fluorescent protein)-MAP
1LC3/LC3 (microtubule associated protein 1 light chain 3). We
detected more GFP-MAP1LC3 puncta upon HS stimulation in
E. coli-infected cells (Figure 4(e)), indicating enhanced autopha-
gosome formation. To confirm this finding, we analyzed the
abundance of the free cytosolic MAP1LC3B-I/LC3B-I and its
lipidated form, MAP1LC3B-II/LC3B-II, which is associated with
autophagosome formation. Under HS conditions, E. coli-infected
MΦ showed increased MAP1LC3B-II:control ratios (Figure 4(f),
quantification and statistical analysis in Figure S3(a)). Given that
autophagosomes undergo a maturation process consisting of
fusions with endosomes and lysosomes, ultimately forming an
autolysosome [35], we assessed the MAP1LC3B-II:control levels
in MΦ where the digestive function of the lysosomes was blocked
with the vacuolar-type H+-ATPase (v-ATPase) inhibitor, bafilo-
mycin A1. HS exposure resulted in increased MAP1LC3B-II:con-
trol levels in the absence or presence of bafilomycin A1-treatment
in E. coli-infected MΦ (Figure 4(f)). This suggests that the accu-
mulation of MAP1LC3-II is due to enhanced induction of autop-
hagy, and not an impairment of autolysosomal function.
SQSTM1/p62 (sequestosome 1) protein is degraded in autolyso-
somes and assists in the targeting of cargo to autophagosomes
[35]. While HS conditions increased Sqstm1 transcription (Figure
4(g)), HS exposure nevertheless decreased the abundance of
SQSTM1 protein in E. coli-infected MΦ (Figure 4(g), quantifica-
tion and statistical analysis in Figure S3(b)); again, indicating
increased autophagy under HS conditions [35]. Of note, the HS-
increased formation of MAP1LC3B-II was independent of
PHOX, again implying that a HS environment induces canonical
autophagy (Figure 4(h), quantification and statistical analysis in
Figure S3(c)). In line with this, transmission electron microscopy
revealed that infected RAW264.7 MΦ treated with HS contained
more double-membraned vacuoles in close proximity to bacteria-
containing lysosomes, which were also more often surrounded by
double membranes (Figure 4(i)). Collectively, these findings
demonstrate that HS promotes autophagy in E. coli-infected
MΦ.
Figure 2. Osmotic stress induced by mannitol does not induce Na+ entry and impairs antibacterial activity. (a) Intracellular Na+ levels were assessed in SBFI-loaded
and E. coli-infected RAW264.7 MΦ by ratiometric live cell imaging. The arrow indicates the addition of 40 mM NaCl (corresponding to an increase in osmolality of 80
mOsm/kg) to infected cells (means ± s.e.m; n = 6). (b) As in (a), but instead of NaCl, 80 mM mannitol (corresponding to an increase in osmolality of 80 mOsm/kg) was
added where indicated (means ± s.e.m; n = 6). (c) BMDM were infected as in Figure 1(f), but with an additional condition using 80 mM mannitol (means ± s.e.m;
n = 24; Kruskal-Wallis test with Dunn’s multiple comparison tests; * p < 0.05).
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High Na+ conditions favor autolysosomal-targeting of
E. coli
Next,wemonitored autophagosomeand autolysosome formation in
RAW264.7 MΦ expressing a tandem monomeric RFP (red fluor-
escent protein)-GFP-tagged MAP1LC3 (RAW-Difluo™ mLC3). In
these cells, the GFP-signal is more sensitive to quenching than the
RFP-signal, which is more stable in the acidic lysosomal environ-
ment [36]. HS treatment increased the formation of RFP+ GFP+
puncta (autophagosomes), as well as the amount of RFP+ GFP−
vacuoles (autolysosomes; Figure 5(a)). This shows that HS condi-
tions increased the formation of both autophagosomes and
Figure 3. HS-boosted antibacterial activity of MΦ is independent of PHOX and NOS2. (a) As in Figure 1(f), but 6 h after infection, BMDM were stained with CM-H2
DCFDA and subjected to flow cytometry. Left section, histogram. Orange area, unstained cells; Gray area, NS; Blue area, HS. Right section, means ± s.e.m; n = 16 −17;
Mann Whitney test; * p < 0.05 (b) As Figure 1(f), but cybb-/- and littermate control (WT) BMDM were used. Intracellular E. coli in CFU relative to mean CFU under NS
WT conditions (means ± s.e.m; n = 11–18; Student’s t test ± Welch correction; * p < 0.05) (c) BMDM were infected with E. coli at the indicated MOI, subjected to
gentamicin protection assays and exposed to NS and HS conditions 2 h after infection ± DPI where indicated. 24 h after infection, nitrite levels were quantified
(means ± s.e.m; n = 6–16; Student’s t test and Mann Whitney test; * p < 0.05). (d) As in (c), intracellular E. coli load 24 h after infection in CFU relative to mean CFU
under the respective NS conditions (means ± s.e.m; n = 5–12; Student’s t test ± Welch correction; * p < 0.05).
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autolysosomes. Next, we assessed whether HS favors the targeting of
E. coli to RFP-positive vacuoles. HS treatment increased the co-
localization of sCFP3A-E. coli with RFP-positive vacuoles from
~33% to ~67% (Figure 5(b)). These findings indicate that HS con-
ditions increase the delivery of E. coli to acidic autolysosomes.
Comparably, we found that HS treatment promoted the delivery of
E. coli to acidic vacuoles stained with the lysosomotropic dye
LysoTracker (Figure 5(c)). Taken together, these findings strongly
indicate that HS conditions increased the induction of autophagy
and the targeting of E. coli to autolysosomes.
Autophagy and acidic compartments are required for
high Na+-increased antibacterial activity of macrophages
To determine the importance of autophagy for the increased
antibacterial defense of MΦ treated with HS, we generated MΦ
from the bone marrow of atg7 cKO (Atg7F/F: Lyz2[lysozyme 2]-
Cre) mice, which have severe cellular impairment of autophagy-
associated phagosomal clearance [37]. While immunoblotting
for ATG7 revealed efficient recombination in Atg7-deficient
MΦ, we detected increased ATG7 protein expression upon HS-
Figure 4. HS increases autophagy in E. coli-infected MΦ. (a and b) GSEA for the HUGO autophagy gene set. Upper section, genes are placed in rank order based on
differences in expression on the x-axis and the curve represents the running enrichment score across the dataset. Bottom section, violin plot indicating the frequency
distribution of the genes within the HUGO gene set by rank. (a) GSEA using the dataset of Ip et al. [2] (b) GSEA of own Agilent microarray data of RAW264.7 MΦ stimulated
with LPS ± 40 mM NaCl for 24 h. (c) Heatmap of gene expression from own Agilent array. Genes plotted are genes within the HUGO autophagy gene set and significantly
differentially expressed (Benjamini Hochberg adjusted p value < 0.05) for the addition of Na+ to LPS (10 ng/mL) treatedMΦ. (d) As in Figure 1(f), but Ulk1, Becn1, Atg2a, Atg4c
and Atg7mRNA levels were quantified (means ± s.e.m; n = 6; Student’s t test ± Welch correction; * p < 0.05). (e) As Figure 1(f), but GFP-MAP1LC3 expressing BMDM were
used. GFP-MAP1LC3 puncta formation was assessed. Representative images of three experiments are displayed. Scale bar: 10 µm. (f) RAW264.7 MΦ were treated as in (d),
but for ½ h ± pretreatment with 100 nM bafilomycin A1. A representative immunoblot of MAP1LC3B and HSP90 levels is displayed. (g) As in (d), Sqstm1was determined on
mRNA (means + s.e.m; n = 6; Student’s t test; * p < 0.05) and protein level. (h) As (f), but Cybb-/- and controls BMDM were used. (i) As in (d), but cells were subjected to
transmission electron microscopy. Representative E. coli-containing vacuoles of two experiments are displayed.
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exposure in controls (Figure 6(a), quantification and statistical
analysis in Figure S4(a)), while its mRNA levels remained unal-
tered (Figure 4(d)), implying that post-transcriptional processes
are involved in ATG7 regulation. HS-treatment failed to increase
antimicrobial activity of Atg7-deficient MΦ, which was main-
tained in control MΦ (Figure 6(a)). Next, we determined the
contribution of lysosomal acidification on HS-increased MΦ
antibacterial function. Pharmacological blockade of the
v-ATPase impaired bactericidal activity of MΦ under normal
salt conditions, and abolished the HS-increased antibacterial
activity of WT MΦ (Figure 6(b)). These data indicate that
lysosomal acidification is a key component of the mechanism
by which HS increases MΦ antibacterial activity.
Low pH levels are known to inhibit protease activities of
several cathepsins such as CTSB (cathepsin B) [38]. Recently
Qi et al demonstrated that CTSB impaired MΦ-dependent
defenses against Francisella novicida [39]. Therefore, it is con-
ceivable that the observed increase in phagosome maturation
and acidification under HS conditions might decrease cathepsin
activity and thereby facilitate increased removal of E. coli. We
used a cell permeable cysteine protease inhibitor (E-64d) that
targets CTSB and other papain-like cysteine proteases [40] in
order to address this possible mechanism (Figure S4(b)). CTSB
activity was not altered by HS (Figure S4(b)). Moreover, HS still
increased the antimicrobial activity of E-64d-treatedMΦ (Figure
S4(c)). Overall, our data demonstrate that autophagy and lyso-
somal acidification critically contribute to the increased antibac-
terial activity under HS conditions, independent of CTSB
activity.
NFAT5 is required for the targeting of intracellular E. coli
to autolysosomes in high Na+
Given that the transcription factor NFAT5 plays a key role in the
adaptation of macrophages to increased extracellular Na+ [5–7],
we tested the contribution of this transcription factor to the
autophagy-mediated pathogen clearance mechanisms described
here. Upon HS treatment of E. coli-infected MΦ, we detected
increasedNfat5mRNAexpression (Figure 7(a)) and protein levels
(Figure 7(b), quantification and statistical analysis in Figure S5(a)).
Silencing ofNfat5 did not affectAtg7mRNA expression (Figure 7
(c)), nor abolish the HS-increased abundance of ATG7 protein
(Figure S5(b)). Additionally, the expression of Ulk1, Atg2a or
Atg4c mRNA was not influenced by Nfat5-silencing (Figure 7
(d)). In line with this, lipidation of MAP1LC3B was not impaired
in Nfat5-deficient MΦ. Moreover, while we detected enhanced
Figure 5. HS facilitates autolysosomal targeting of E. coli. (a) As in Figure 1(f), but RFP-GFP-mLC3 RAW264.7 MΦ were used. RFP+GFP− and RFP+GFP+-puncta were
counted per cell. Confocal images: GFP, green; RFP, red. Scale bar: 10 µm. At least 287 MΦ from two independent experiments (bars: median scores; Mann-Whitney
test; * p < 0.05). (b) As in (a), but sCFP3A-E. coli were used. Confocal images: GFP, green; RFP, red; sCFP3A-E. coli, blue. Scale bar: 10 µm. Rate of E. coli-sCFP3A/
RFP+GFP–colocalization per cell. At least 118 MΦ from two independent experiments (bars: median scores; Mann-Whitney test; *p < 0.05). (c) RAW264.7 MΦ were
infected with sfGFP-E. coli as in Figure 1(f), but stained with LysoTracker. Confocal images: sfGFP-E. coli, green; LysoTracker, red; DAPI (DNA), blue. Scale bar: 10 µm.
Colocalization of sfGFP-E. coli and LysoTracker per MΦ. At least 166 MΦ from two independent experiments were analyzed (bars: median scores; Mann-Whitney test;
* p < 0.05).
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MAP1LC3B-II:control levels under NS conditions in Nfat5-
silenced MΦ, there was still an increase in MAP1LC3B-II:control
levels uponHS exposure, indicating that NFAT5 is dispensable for
the increased formation of these components of the autophagic
machinery (Figure 7(e)).
Next, we tested whether NFAT5 is involved in autolysosomal
formation. To address this, we determined the impact of NFAT5
on the formation of autophagosomes and autolysosomes in RFP-
GFP-mLC3 RAW264.7MΦ as before. HS treatment increased the
formation of RFP+ GFP+ puncta (autophagosomes), as well as the
number of RFP+ GFP− vacuoles (autolysosomes) in control cells.
By contrast, Nfat5-silencing increased the formation of RFP+
GFP+ vesicles but suppressed the formation RFP+ GFP− puncta
under NS conditions (Figure 7(f)), in line with our finding of
enhanced MAP1LC3B-II:control levels in Nfat5-deficient MΦ
(Figure 7(e)). This suggests that NFAT5 is important for the
degradation of MAP1LC3B-II under NS conditions. However,
upon HS exposure Nfat5-silencing blunted both the formation
of RFP+ GFP+ and RFP+ GFP− vesicles (Figure 7(f)). Overall, this
indicates that Nfat5 plays an important role in autophagosome
and autolysosome formation, a phenotype which becomes further
evident upon exposure to HS. In line with this, we found that the
targeting of E. coli to acidic compartments was severely impaired
inNfat5-deficientMΦ upon exposure to HS (Figure 7(g)). Finally,
we tested the contribution of Nfat5 in mediating HS-enhanced
bacterial elimination. Nfat5-silencing abolished the HS-increased
MΦ antibacterial activity, which was preserved in MΦ treated
with control ns-siRNA (Figure 7(h)). Altogether, these findings
demonstrate that NFAT5 does not mediate the increased expres-
sion of components of the autophagy machinery, nor does it play
a direct role in increasing MAP1LC3B-II formation upon HS
treatment. However, NFAT5 is required for the HS-increased
formation of autophagosomes and autolysosomes, and the target-
ing of E. coli to acidic lysosomal compartments; ultimately, these
result in enhanced intracellular bacterial elimination.
Blunted AKT and MTOR activation does not account for
HS-increased antibacterial activity
Previously, we demonstrated that HS conditions impair
AKT activation in MΦ [27]. Since AKT and MTOR block-
ade is known to induce autophagy [25], we tested whether
pharmacological blockade of cells with the AKT and
MTOR inhibitor Torin1 [41] under NS conditions is suffi-
cient to mimic HS-boosted antimicrobial MΦ activity.
Administration of Torin1 abolished AKT activation and
increased MAP1LC3-II:control protein abundance in NS
conditions, i. e. independent of increased extracellular
Na+, due to ATP-competitive inhibition of MTORC1/2
[41]. Additionally and confirming earlier findings [27],
we found that HS conditions blunted AKT activation
in MΦ (Figure 8(a), quantification and statistical analysis
in Figure S6(a-b)). In line with an earlier publication [42],
Torin1-treatment, did not abrogate the HS-triggered
induction of the osmoprotective transcription factor
NFAT5 (Figure 8(b), quantification and statistical analysis
in Figure S6(c)). Although treatment with Torin1
increased autophagy in MΦ under NS conditions, as
assessed with RFP-GFP tagged MAP1LC3 reporter cells
(Figure 8(c)), Torin1-treatment did not increase the tar-
geting of intracellular E. coli to autolysosomes under NS
conditions (Figure 8(d)). Consequently, MΦ exposed to
Torin1 in NS conditions only tended to increase the kill-
ing of intracellular E. coli (adjusted p value = 0.08; Figure
8(e)). By contrast, HS increased the targeting of E. coli to
autolysosomes (Figure 8(d)) and killing of E. coli (Figure 8
(e)), either in the absence or presence of Torin1. Together,
these data suggest that increased autolysosome formation
alone is not sufficient to improve bacterial elimination,
but the targeting of E. coli to autolysosomes is also
required for HS-increased antibacterial activity.
Figure 6. Autophagy and lysosomal acidification are required for high Na+-increased antibacterial activity. (a) As in Figure 1(a), but BMDM from atg7 cKO and
littermate controls were used. Upper section, intracellular E. coli load in CFU relative to mean CFU under NS conditions (means ± s.e.m; n = 18–20; Student’s t test +
Welch correction or Mann Whitney test, * p < 0.05). Lower section, Immunoblotting of ATG7 and ACT. (b) As in Figure 1(a), but RAW264.7 MΦ were pretreated with
100 nM bafilomycin A1. Intracellular E. coli load in CFU relative to mean CFU under NS conditions (means ± s.e.m; n = 11–12; Student’s t test or Mann Whitney test, *
p < 0.05).
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The presence of HIF1A is necessary for HS-mediated
autophagy induction and antibacterial activity
To identify potential mechanisms by which HSmediated its effects
on autophagy, we performed a GSEA for positive and negative
regulators of autophagy with our microarray data obtained from
LPS-stimulated RAW246.7MΦ in NS andHS as before.We found
that HS did not affect the expression of negative regulators of
autophagy (NES 1.27, FDR q value 0.191; Figure 9(a)). However,
positive regulators of autophagy were increased withHS (NES 2.36,
FDR q value 0.000; Figure 9(b)). This included the transcription
factorHif1a and its target Bnip3 (BCL2/adenovirus E1B interacting
Figure 7. NFAT5 is required for HS-facilitated targeting of intracellular E. coli to autolysosomes. (a to d) As in Figure 1(f), but non-silencing siRNA (ns siRNA) and
Nfat5-specific siRNA (Nfat5 siRNA)-treated RAW264.7 MΦ were used. (a) Nfat5 mRNA levels (means ± s.e.m; n = 6; Student’s t test or Mann-Whitney test, * p < 0.05).
(b) Immunoblotting of NFAT5 and ACT. (c) As (a), but Atg7 mRNA levels (means ± s.e.m; n = 6; Student’s t test ± Welch correction). (d) As (a), but Ulk1, Becn1, Atg4c
and Atg2a mRNA levels (means ± s.e.m; n = 6; Student’s t test ± Welch correction; * p < 0.05). (e) Immunoblotting and densitometry of MAP1LC3B/LC3 and ACT ½
h after infection (n = 6; paired Student’s t test or Wilcoxon signed rank test; *p < 0.05). (f) As in Figure 1(f), but ns siRNA- and Nfat5 siRNA-treated RFP-GFP-mLC3
RAW264.7 MΦ were used. RFP+ and RFP+GFP+-puncta were counted per cell. At least 290 cells from two independent experiments (bars: median scores; Kruskal
Wallis test with Dunn’s Multiple Comparison Test, * p < 0.05). (g) As Figure 1(f), but RAW264.7 MΦ were used and stained with LysoTracker. Colocalization of sfGFP-
E. coli and LysoTracker per cell. At least 101 cells from at least two independent experiments (bars: median scores; Kruskal Wallis test with Dunn’s Multiple
Comparison Test, * p < 0.05). (h) As in Figure 1(a), but ns siRNA- and Nfat5 siRNA-treated RAW264.7 MΦ were used. Intracellular E. coli load in CFU relative to mean
CFU under NS conditions (means ± s.e.m; n = 11–12; Student’s t test ± Welch correction, * p < 0.05).
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protein 3; Figure 9(c)) [43,44]. These findings were validated with
E. coli-infected MΦ that exhibited similar increased expression of
Hif1amRNA and protein with HS treatment (Figure 9(d), quanti-
fication and statistical analysis in Figure S7(a)). In addition to the
Hif1a-target Bnip3, HS also increased the expression of the glyco-
lyticHif1a-targets Slc2a1 (solute carrier family 2 [facilitated glucose
transporter], member 1) and Pgk1 (phosphoglycerate kinase 1;
Figure S7(b)) [45,46].
To validate the role of Hif1a in HS-increased autophagy and
antibacterial activity, we transfected Hif1a siRNA into
RAW264.7 MΦ, which almost completely extinguished Hif1a
expression in NS and HS conditions, leading to a suppression of
Bnip3 mRNA, and abrogation of the HS-increased Bnip3 expres-
sion (Figure S7(c)). In parallel, HS treatment of Hif1a-silenced
MΦ diminished MAP1LC3B-II:control levels (Figure 9(e), quan-
tification and statistical analysis in Figure S7(d,e) and impaired the
HS-increased formation of RFP+ GFP+ puncta (autophagosomes)
and RFP+ GFP− vacuoles (autolysosomes; Figure 9(f)). Together,
these data demonstrate that HIF1A is required for HS-increased
autophagy. To assess the role of Hif1a in improving bacterial
elimination in HS conditions, we next tested the antibacterial
activity of Hif1a-silenced RAW264.7 MΦ (Figure 9(g)) and of
Hif1a-deficient BMDM (hif1a cKO, Hif1aF/F: Lyz2-Cre; Figure 9
(h)). In both theHif1a knock-down and hif1a cKO situations, the
effect of HS in increasing antimicrobialMΦ activity was abolished
(Figure 9(g,h)). From these data we conclude that HS-increased
induction of autophagy is coordinated by HIF1A, which is criti-
cally required for mediating these HS enhanced antibacterial
defenses.
Finally, we set out to address the relationship between
HIF1A and NFAT5 in mediating the effects of Na+ on MФ
activity. We first tested the effect of Hif1a expression on Nfat5
and vice versa. Hif1a-silencing did not affect the expression of
Nfat5, nor did it abrogate the HS-increased expression of
Nfat5 mRNA (Figure S8(a)) and protein (Figure S8(b)).
By contrast, Nfat5-silencing did not affect Hif1a mRNA and
protein expression in normal salt conditions, but it did abolish the
HS-increased Hif1a mRNA (Figure S8(c)) expression, and also
reduced HIF1A protein levels (Figure S8(d)). Since HS is still able
to induce autophagy in Nfat5-silenced cells (Figure 7(d–f)), and
Hif1a is required for HS-triggered autophagy induction (Figure 9
(e–h)), these findings suggest a separation between the relative
expression level of HIF1A and its role in bacterial elimination:
while the complete absence of HIF1A abolishes HS-enhanced
antibacterial activity, the increased expression of HIF1A induced
by HS is dispensable. To corroborate this result, we increased
HIF1A accumulation in Nfat5-silenced cells using a chemical
stabilizer of HIF1A, DMOG (dimethyloxallyl glycine) [47,48],
and tested for its impact on antibacterial activity. These experi-
ments revealed that increasing HIF1A levels in Nfat5-silenced
cells is not able to restore the impaired antimicrobial activity
under HS conditions (Figure S8(e,f)).
Figure 8. Blunted AKT and MTOR activation does not account for HS-augmented antibacterial activity. (a) As in Figure 1(f), RAW264.7 MΦ were pretreated ± 1 µM
Torin1 and infected ± HS. Cells were harvested ½ h post infection. Immunoblots of p-AKT, AKT, MAP1LC3B and ACT levels are displayed. (b) As in (a), but 2 h post
infection, NFAT5 and ACT levels were assessed. (c) As in (b), but RFP-GFP-mLC3 RAW264.7 MΦ were used. A representative confocal image out of two experiments is
shown. Scale bar = 10 µm. (d) As in (c), but sCFP3A-E. coli were used. Rate of E. coli-sCFP3A/RFP-colocalization per cell. At least 184 MΦ from two independent
experiments (bars: median scores; Mann Whitney test; * p < 0.05). (e) As in (b), but intracellular E. coli load is displayed 2 h after infection in CFU relative to mean CFU
under NS conditions (means ± s.e.m; n = 23–24; ANOVA with Bonferroni’s test; * p < 0.05).
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Taken together, we demonstrate here that HS conditions
(i) require the presence of HIF1A for increased autophagy
induction, and (ii) facilitate targeting of E. coli to acidic
autolysosomal compartments via increasing NFAT5
(Figure 10).
Discussion
Components of the autophagy pathway are known to promote
phagosome maturation and acidification and thereby e. g. foster
degradation of the yeast Saccharomyces cerevisiae [49],
Figure 9. The presence of HIF1A is required for HS-triggered autophagy induction and antibacterial activity. (a and b) GSEA for negative (a) and positive (b)
regulators of autophagy. Upper section, genes are placed in rank order based on differential expression between the groups on the x-axis and the curve represents
the running enrichment score across the dataset. Bottom section, violin plot indicating the frequency distribution of the genes within the respective GO of positive
enrichment of autophagy regulators by rank. (c) Heatmap of gene expression from own Agilent array. Genes plotted are genes within the HUGO autophagy
regulatory gene set, which are upregulated and significantly differentially expressed (Benjamini Hochberg adjusted p value < 0.05) with the addition of NaCl to LPS-
treated MΦ. (d) Left and right section, as in Figure 1(f), but Hif1a and Bnip3 mRNA levels were quantified (means ± s.e.m; n = 6; Student’s t test or Mann Whitney test;
* p < 0.05). Middle section, HIF1A and ACT protein levels. (e to g) As in Figure 1(f), but ns siRNA- and Hif1a-specific siRNA (Hif1a siRNA)-treated RAW264.7 MΦ were
used. (e) Upper section: HIF1A and ACT protein levels 4 h after infection. Lower section: MAP1LC3B and HSP90 as Figure 4(f). (f) Instead of RAW264.7 MΦ, RFP-GFP-
mLC3 RAW264.7 MΦ were used. Confocal images: GFP, green; RFP, red. Scale bar = 10 µm. Representative images out of two experiments are shown. (g) As in Figure
1(f), intracellular E. coli load, CFU relative to mean CFU under ns siRNA-treated NS conditions (means ± s.e.m; n = 12; Mann Whitney test; * p < 0.05) (h) As in Figure 1
(f), but BMDM from hif1a cKO and littermate controls were used. Intracellular E. coli load in CFU relative to mean CFU under NS conditions is displayed (means ± s.e.
m; n = 18; Student’s t test or Mann Whitney test; * p < 0.05).
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Mycobacterium tuberculosis [50] and a virulent adherent-invasive
E. coli strain [51]. In this work, we demonstrate that HS induces
autophagy, favors autolysosomal formation and targeting of E. coli
to acidic lysosomal compartments which, ultimately, results in
enhanced intracellular bacterial degradation. Of note, we found
in our study that ATG7was not required for antimicrobial control
of E. coliHB101 under normal cell culture conditions (i. e. normal
salt conditions). In line with this, Chiu et al reported for instance
that under normal cell culture conditions ATG7 was dispensable
for control of Salmonella enterica serovar Typhimurium in
RAW267.4 MΦ, while an antimicrobial compound increased
autophagy in this situation and thereby augmented anti-
Salmonella control [52]. Moreover, in line with others [53], our
data suggest that compared to an adherent-invasiveE. coli [51], the
E. coli HB101 strain used in our study is a poor inducer of
autophagy under normal salt conditions. Hence autophagy does
not participate in removal of E. coli HB101 under normal salt
conditions. However, if infected MΦ are incubated under HS
conditions, (i) autophagy becomes functional and (ii) ultimately
contributes to antimicrobial control by increasing autophagic
degradation processes and facilitating the targeting of E. coli to
acidic lysosomal compartments. Moreover, our data demonstrate
that the autophagic phenotype is largely dependent on the lysoso-
mal acidification. Our data also suggest that modulation of CTSB
activity is unlikely to be involved in HS-increased antimicrobial
activity. However, it is possible that other hydrolases might be
involved in enhanced lysosomal pathogen elimination.
Since autophagy and autophagy-associated pathways play an
important role in antigen-processing and presentation in the
context of major histocompatibility complex class II and class
I molecules [54], our findings might explain enhanced antigen-
processing in dendritic cells exposed to high salt concentrations
[15]. Several bacteria, viruses and parasites developed strategies
to evade autophagy-mediated immune surveillance [24,55–58].
It is conceivable that local increases in extracellular Na+ might
help overcome pathogen-triggered strategies to circumvent
autophagy-mediated degradation. Moreover, Na+-increased
autophagy might facilitate clearing infected and inflamed tissues
from dead cells and thereby curtail inflammatory responses
upon sterile tissue damage as well [37].
In contrast to LC3-associated phagocytosis [59], we demon-
strate that HS-boosted MAP1LC3B-lipidation and autophagy are
independent of PHOX. Using our transcriptomic data, we identi-
fied HIF1A as a novel regulator of autophagy upon HS stress. In
addition to low oxygen tensions, a plethora of other stimuli is able
to induce HIF1A accumulation [60–62]. Our finding of HS-
increased HIF1A accumulation in infected MΦ conforms to ear-
lier reports that hypertonic conditions are able to induce HIF1A
in mouse lung epithelial cells [63]. The mechanisms, however, by
which HS conditions boost HIF1A accumulation under condi-
tions of ample oxygen, are unknown. Given that canonical HIF1A
accumulation is known to be regulated on a posttranslational
manner [60–62], it is possible that HS induced HIF1A stabiliza-
tion might involve posttranscriptional/posttranslational processes
as well.
In MΦ it is largely unexplored how NFAT5- and HIF1A-
dependent pathways are intertwined. Hypoxia is reportedly
able to induce NFAT5 in synovial MΦ obtained from patients
suffering from rheumatoid arthritis [10]. We provide evidence
that HIF1A is not important for HS-induced NFAT5 expres-
sion, suggesting that mechanisms other than HIF1A may be
involved in the hypoxia-induced NFAT5 accumulation. By
contrast, while Nfat5-deficient cells had HIF1A present, we
find that NFAT5 is essential for the HS-increased HIF1A
accumulation. The mechanisms underlying this observation
remain elusive and require further studies.
HIF1A has been implicated in regulating autophagy at
various levels in different cells [26,64–68]. While we confirm
that HIF1A is essential for inducing autophagy, our data
suggest that this is independent of increasing its cellular
expression upon HS treatment. It remains unclear, how
HIF1A activates autophagy upon exposure to HS conditions.
Bellot et al proposed that hypoxia induces HIF1A-dependent
expression of Bnip3. This disrupts B-cell lymphoma 2-BECN1
complexes without triggering cell death but ultimately initi-
ates autophagy via free BECN1 [26]. Alternatively, osmotic
stress might, for instance, induce subcellular membrane
defects [69,70] or activate various ion channels or transporters
[71] which result in cellular stress responses including activa-
tion of HIF1A.
Confirming earlier findings [27], we showed that elevated
extracellular Na+ concentration blunts AKT signaling. In con-
trast to pharmacological blockade of AKT- andMTOR signaling
[72,73], HS-conditions result in reduced AKT activation and
simultaneous induction of HIF1A. The molecular mechanisms
for this finding require further investigation. In line with others
[74], we provide evidence that MTOR-AKT inhibition under NS
conditions increases autophagy as well as autophagosome and
autolysosome formation. Surprisingly, this is not sufficient to
mimic enhanced antimicrobial activity under NS conditions.
However, in contrast to HS-treated cells, AKT and MTOR
inhibition under NS conditions was not linked with enhanced
targeting to autolysosomes. This strongly suggests that increases
in autophagy and autolysosome formation are not sufficient but
that in addition HS-triggered subcellular targeting of intracellu-
lar E. coli to autolysosomes is critically required for HS-
enhanced antimicrobial MΦ activity.
In this study, we provide evidence that NFAT5 coordinates
targeting of E. coli to autolysosomes under HS-conditions. In
contrast to a recent study [75], but in line with findings demon-
strating that NFAT5 does not affect expression of genes involved
in autophagy such as Becn1 under normal salt conditions [76], our
findings suggest that the osmoprotective transcription factor
NFAT5 is not directly involved in autophagy induction. Our
data demonstrate that NFAT5 is rather involved in regulation of
subcellular trafficking, including formation of autolysosomes, and
targeting of E. coli to these acidic compartments. In C. elegans, the
expression of genes involved in endosomal trafficking and lyso-
somal biogenesis are required for survival upon exposure to
hypertonic conditions [77]. Moreover, hypertonic stress condi-
tions alter intracellular trafficking in the kidney proximal tubule
cell line (LLC-PK) and promoted microtubule-dependent cluster
formation [34]. Given that microtubular trafficking is implicated
in formation of autophagosomes and its fusion with endosomes
[78,79], we speculate that NFAT5 might be involved in this state
of affair as well. Alternatively, rearrangements of actin cytoskele-
ton might be involved in this process [14]. However, how NFAT5
governs autophagosome and autolysosome formation and
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subcellular targeting of E. coli upon exposure to increases in
extracellular Na+ requires further investigation.
Materials and methods
Reagents and antibodies
All media (RPMI, DMEM) and PBS buffers were purchased from
Gibco (61870–010; 41966–029; 14190–094). NaCl was purchased
from Merck. LPS (E. coli O111:B4) and DPI were purchased from
Sigma Aldrich (D2926). Torin1 was purchased from Tocris (4247);
E-64d was obtained from Hycultec (HY-15282). Ionomycin
(407952) was purchased from CalbioChem. ATP (tlrl-atpl) and
bafilomycin A1 (tlrl-baf1) were obtained from Invivogen. The
prolyl-hydroxylase inhibitor DMOG was purchased from
Cayman Chemical (71210). For immunoblotting, the following
antibodies were used: rabbit anti-ACT (A2066; Sigma-Aldrich);
rabbit-anti-HSP90A/B (Santa Cruz Biotechnology, sc-7947), rabbit
anti-NFAT5 (Thermo Scientific, PA1-023), rabbit anti-MAP
1LC3B (Novus Biologicals, NB100-2220), rabbit anti-ATG7 (Cell
Signaling Technology, D12B11) rabbit anti-p-AKT (Cell Signaling
Technology, 4060S), rabbit anti-AKT (Cell Signaling Technology,
9272S), rabbit anti-SQSTM1 (Sigma Aldrich, P0067), rabbit anti-
HIF1A (Cayman Chemical, 10006421). As secondary antibody, we
used swine anti-rabbit HRP (P0399, Dako).
Cells and bacteria
RAW264.7 MΦ and RFP-GFP-mLC3 RAW264.7 MΦ (RAW-
DifluoTM mLC3 cells; purchased from Invivogen and used accord-
ing to the instructions of the supplier) were used. BMDM from
C57BL/6WTmice and various knock out and transgenemice were
generated in Teflon® bags, as described earlier [80]. In addition to
C57BL/6 WT mice (Charles River Breeding Laboratories, Sulzfeld,
Germany), we used GFP-MAP1LC3 mice [81], cybb-/- mice [82]
and their littermate controls, atg7 cKO (Atg7F/F: Lyz2-Cre) mice
[83,84] and their littermate controls, and hif1a cKO (Hif1aF/F: Lyz2-
Cre) mice [85] and their respective littermate controls as described
earlier [86,87]. For infection experiments, we used E. coliHB101 or,
for immunofluorescence studies, E. coli harboring pWRG167 [88]
and pWRG29 for constitutive expression of superfolder GFP
(sfGFP) or super cyan fluorescent protein 3A (sCFP3A), respec-
tively. The gene for sCFP3A [89] was PCR-amplified with primers
XbaI-sCFP-for (TCC TCTAGATTTAAGAAGGAGATATAC
ATA TGG TGA GCA AGG GCG AGG AG) and sCFP-HindIII-
rev (TTA AAG CTT GCA TGC CTG CAGGTC TGG ACA TTT
ACT TGT ACA GCT CGT CCA TG). The fragment was digested
using XbaI and HindIII and subsequently ligated in the similarly
treated vector pFPV25.1 [90] which resulted in pWRG29. For
determination of minimal inhibitory concentrations a reference
E. coli strain (ATCC 25922) was used in addition to E. coliHB101.
RNA interference in macrophages
RNA interference was performed as described earlier [1,91]
and cells were subjected to experimental conditions.
Determination of minimal inhibitory concentrations
Bacteria were grown on blood agar and subjected to serial
dilutions of gentamicin in regular cell culture media under NS
and HS conditions. Minimal inhibitory concentration was
determined after overnight incubation.
Figure 10. Schematic of mechanisms involved in HS-increased antibacterial activity of MΦ.
AUTOPHAGY 13
Measurement of intracellular ion concentrations
Prior to infection, cells were seeded on FluoroDishTM Plates
(World Precision Instruments, FD3510-100) and loaded with
fluorescence dyes for Na+ (90 min staining with 0.9 µM SBFI
[Thermo Scientific, S1264] at 37°C), K+ (90 min staining with
0.9 µM Potassium-binding benzofuran isophthalate [Thermo
Scientific, P1267] at 37°C), or Ca2+ (15 min staining with
1.6 µM Fura-2 [Thermo Scientific, F1221] at room temperature),
in Tyrode solution (140 mM NaCl, 4 mM KCl, 1 mM MgCl2,
5 mM HEPES, 1 mM CaCl2, 10 mM Glucose) respectively. After
½ h of infection and additional ½ h of incubation in Tyrode
solution containing gentamicin (100 µg/ml), cells were mounted
on the stage of an epifluorescence microscope (Motic Model
410E). SBFI, PBFI or Fura-2 was alternatingly excited at 340 and
380 nm. Emitted fluorescence passed through appropriate emis-
sion filter sets, was acquired using a photomultiplier for 10 min
and analyzed using IonWizard software (IonOptix Cooperation)
as described earlier [92]. Fluorescence intensities were back-
ground substracted and normalized to F340/F380 at t = 0 min.
Macrophage infection experiments
Intracellular bacterial survival was assessed using a gentamicin
protection assay as described earlier [1]. Briefly, RAW264.7 MΦ
or BMDM were infected with E. coli HB101 with a MOI of 100
(unless indicated otherwise) for 1 h. Subsequently, extracellular
bacteria were removed by washing with PBS. Gentamicin
(100 µg/ml) was added to cell culture medium for 1 h. For
long long term experiments (24 h) cells were washed with PBS
and incubated with 25 µg/ml gentamicin for an additional 22 h.
Where indicated, cells were exposed to additional 40 mM NaCl
in the medium directly after infection or 2 h after infection. The
infection was terminated at 2 h or 24 h post infection by lysis of
the cells using 0.1% Triton-X and 0.05% Tween 80 in PBS. The
number of remaining intracellular bacteria was determined by
generating serial dilutions of the lysate in PBS onMüller-Hinton
agar plates. Colony forming units (CFU) were counted after
incubation of the plates at 37°C overnight. For immunofluores-
cence, cells were seeded on cover slips, infected with sfGFP or
sCFP3A expressing E. coliHB101 and treated as described above.
Instead of lysis, cells were fixed with 3.5% paraformaldehyde
(PFA) for 15 min at RT. Subsequently, staining of the actin
cytoskeleton using Phalloidin 647 (Invitrogen, A22287) was
performed in blocking solution (5% BSA, 2% goat serum in
PBS) containing 0.1% saponin for 2h at RT. To visualize DNA
and mount the stained cells, we used Prolong Gold antifade
reagent containing DAPI (Invitrogen, P36931). LDH release of
infected MΦ was performed as described previously [93].
Phagocytosis assays
BMDMs were seeded in low adherence plates (Sigma Aldrich,
CLS3473-24EA) and stimulated with FITC-labelled 1 µm
Latex beads (Sigma Aldrich, L4655). Cells were kept for ½
h in normal cell culture media ± 40 mM NaCl and kept at 37°
C and 4°C to assay internalization and attachment of beads by
flow cytometry, respectively. After incubation and washing,
cells were assessed by flow cytometry.
Quantification of nitrite and ROS production
As indicator of NO production, accumulation of nitrite in the cell
supernatants was quantified by Griess reaction as described earlier
[1]. For intracellular ROSmeasurements, infected cells were kept ±
40mMNaCl for 6 h in low adherence plates. ½ h before collecting
of the cells for flow cytometry, 10 µM of CM-H2DCFDA (Thermo
Fisher, C6827) was added and cells were analyzed.
Measurement of CTSB activity
Cells were infected as described. 2 h post infection, CTSB activity
was measured using the ‘Cathepsin B Activity Assay Kit’ (abcam,
ab65300) according to the manufacturer’s instructions.
Immunoblotting
For immunoblotting, cells were lysed at the indicated time points
as described earlier [1,94]. In order to assess the lipidation status
of MAP1LC3B, we used Mini-PROTEAN® TGXTM gradient
gels from 4% – 20% (Bio-RAD, 456–1094) for sodium dodecyl
sulfate polyacrylamide gel electrophoresis and, for blotting, poly-
vinylidene difluoride membranes (Immobilon®-PSQ, Millipore,
ISEQ00005). After staining with appropriate antibodies, signals
were visualized by the Chemo Star Imager (Intas Science
Imaging Instruments, Göttingen, Germany). Densitometry of
western blots was determined via ImageJ measurements
(Version 1.50b; Rasband, W.S., ImageJ, U. S. National
Institutes of Health, https://imagej.nih.gov/ij/).
Gene expression microarray
RAW 264.7MΦwere stimulated with or without 10 ng/ml LPS in
the absence or presence of additional 40 mM NaCl in the cell
culture media for 24 h. Total RNA was extracted with Trifast®
(PeqLab) according to the manufacturer’s instruction.
Transcriptional profiles were assessed using an Agilent Whole
Mouse Genome Oligo Microarrays (8x60K). RNA quality and
integrity were determined using the Agilent RNA 6000 Nano
Kit on the Agilent 2100 Bioanalyzer (Agilent Technologies).
RNA was quantified by measuring A260 on the ND-1000
Spectrophotometer (NanoDrop Technologies, Wilmington, DE,
USA). Sample labelling was performed as detailed in the ‘One-
Color Microarray-Based Gene Expression Analysis’ protocol (p/n
G4140-90040). Briefly, 100 ng of each total RNA samples was used
for the amplification and labelling step using the Agilent Low
Input Quick Amp Labelling Kit (Agilent Technologies,
5190–2305). Yields of cRNA and the dye-incorporation rate
were measured with the ND-1000 Spectrophotometer. The hybri-
dization procedure was performed according to the ‘One-Color
Microarray-Based Gene Expression Analysis’ protocol (p/n
G4140-90040) using the Agilent Gene Expression Hybridization
Kit (Agilent Technologies). Briefly, 0.6 µg Cy3-labeled fragmented
cRNA in hybridization buffer was hybridized overnight (17 hours,
65°C) to AgilentWholeMouseGenomeOligoMicroarrays 8x60K
(AMADID 028005) using Agilent’s recommended hybridization
chamber and oven. Following hybridization, themicroarrays were
washed once with the Agilent Gene ExpressionWash Buffer 1 for
1 min at room temperature followed by a second wash with
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preheated Agilent Gene Expression Wash Buffer 2 (37°C) for
1 min. Fluorescence signals of the hybridized Agilent
Microarrays were detected using Agilent’s Microarray Scanner
System G2505C (Agilent Technologies, Santa Clara, CA, USA).
The Agilent Feature Extraction Software (FES) 10.7.3.1 was used
to read out and process the microarray image files.
Microarray analysis
Microarray data was analyzed using the R package Limma
within the R statistical environment using the standard work
flow recommended for Agilent arrays. Briefly the data was read
in, background corrected and quantile normalized between
arrays. Probes of low expression were removed from the dataset.
Low expressed probes were defined as probes which did not have
an expression value greater than 110% of the 95th quantile of the
negative control probes on each chip for at least 3 chips in the
dataset. To identify differential expression of genes an appro-
priate liner model was fitted.
Gene set enrichment analyzes
GSEAwas carried out using the java based graphical user interface
[95] using a pre-ranked list with the classic enrichment statistic.
For the data from Ip et al as there was no replicates, a ranked list
was produced based on log2 fold change between conditions. For
our dataset, genes were ranked based on the inverse of the unad-
justed p value with the sign of the log2-fold change. GSEAwas ran
against 2 gene lists. The HUGO gene list consisted of all the genes
annotated as ‘Autophagy associated’ byHUGO and the Kegg gene
list is the ‘Kegg pathway’ for autophagy. For Autophagy regulation
the gene ontology lists GO:1903599 ‘positive regulation of
Autophagy’ and GO:0010507 ‘negative regulation of autophagy’
were used.
RNA isolation, reverse transcriptions, real-time PCR, and
relative quantification
RNA extraction and reverse transcription were performed as
described earlier [94]. We used the following TaqMan assays
for quantitative real-time PCR (Applied Biosystems): Hprt1
(Mm00446968_m1), Atg2a (Mm01212087_m1), Atg4c
(Mm01259886_m1), Ulk1 (Mm00437238_m1), Becn1
(Mm01265461_m1), Nfat5 (Mm00467257_m1), Atg7
(Mm00512209_m1), Hif1a (Mm01283760_m1), Bnip3
(Mm01275600_g1), Pgk1 (Mm01225301_m1), Slc2a1
(Mm00441480_m1). Quantitative real-time PCR was carried
out with an ABI Prism 7900 sequence detector (Applied
Biosystems, Darmstadt, Germany). Subsequently, data were
processed and analyzed using the ΔΔCT method. We set
normalized ratio of target mRNA:control Hprt1 in infected
cells kept under normal salt conditions to 1.
Analysis of autophagosome and autolysosome formation
as well as subcellular localization of E. coli
To monitor autophagosome and autolysosome formation as
well as autolysosomal targeting of E. coli, RFP-GFP-mLC3
RAW264.7 MΦ were seeded on coverslips and infected with
E. coli HB101 or sCFP3A-E. coli HB101 and subjected to
gentamicin-protection assays as described above. 2 h post
infection, cells were fixed with 3.5% PFA and mounted with
Prolong Gold containing DAPI (Invitrogen). To assess target-
ing of E. coli to acidic vacuoles, RAW264.7 MΦ were seeded
on coverslips and infected with sfGFP-E. coli HB101 and
treated as described above. 1.5 h after infection, cells were
stained with 0.5 µM LysoTracker (LysoTracker Red® DND-99,
Thermo Fisher, L7528). 2 h post infection, cells were fixed
with 3.5% PFA and mounted with Prolong Gold containing
DAPI. Images were collected with a Leica TCS SP5 confocal
laser microscope. Data were acquired and processed using
Leica Application Suite (v2.7.3.9723), Power Point
(v14.0.7192.5000) and Photo Shop CS6.
For autophagosome and autolysosome formation GFP+
RFP+ and GFP− RFP+ puncta per cell were counted. RFP+
GFP+ and RFP+ GFP− puncta per cell were manually counted
in RFP-GFP-mLC3 RAW264.7 MΦ. The maximum number
of puncta per cell counted was 25. To assess targeting of
E. coli to autolysosomes, colocalization of RFP+ puncta (auto-
lysosomes) with intracellular sCFP3A-E. coli was determined
as per cent of total intracellular bacteria per cell. To assess
targeting of E. coli to acidic vacuoles, colocalization of
LysoTracker-positive vacuoles with intracellular sfGFP-
E. coli was determined as per cent of total intracellular bac-
teria per cell.
Transmission electron microscopy
RAW264.7 MΦ were infected as described above. Two
hours after infection, cells were washed twice with PBS and
harvested in PBS containing 2% gelatin (Sigma Aldrich,
G9391-100 g). Afterwards, the infected cells were routinely
fixed in 0.1 M cacodylate-buffered Karnovsky solution (2.5%
glutaraldehyde [Electron Microscopy Sciences, 16,400] and
2% paraformaldehyde [Electron Microscopy Sciences,
19,200]) overnight at room temperature, followed by postfixa-
tion in 1% osmium tetroxide (Electron Microscopy Sciences,
19,110) for 2 h. Samples were then dehydrated in graded
ethanols (Sigma Aldrich, 32221-1l-M), and embedded in the
EMbed-812 epoxy resin (Electron Microscopy Sciences,
14,900, 13,710, 19,000, 13,600]). After 48 h heat polymeriza-
tion at 60°C, semithin (0.8 µm) sections were cut, stained with
a toluidine blue (AgarScientific, R1727) and basic fuchsine
(Polysciences, 635) solution, and after selection of appropriate
areas of interest the epon block was trimmed for ultrathin
sectioning. Ultrathin (80 nm) sections were cut with a dia-
mond knife on a Reichert Ultracut-S ultramicrotome (Leica,
Wetzlar, Germany) and double contrasted with aqueous 2%
uranyl acetate (Fluka, 94,260) and lead citrate solutions (Leica,
169,707,235) for 10 min each. The sections were examined in
a LEO912AB transmission electron microscope (Zeiss,
Oberkochen, Germany) operating at 100 kV.
Statistical analysis
Results are expressed as mean ± s.e.m. (unless indicated other-
wise). Statistical significance was tested with Prism v5.0 or v6.0
software (GraphPad). We tested normality distribution with the
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Kolmogorov-Smirnov test. When comparing normal distributed
datasets, two groups were compared using the unpaired two-
tailed Student t test if equal variances were assumed. If unequal
variances were detected, unpaired two-tailed Student t test with
Welch correction was used. Mann-Whitney U test was applied
whenever the data points were not normally distributed. When
comparing more than two groups of non-normally distributed
or normally distributed datasets the Kruskal-Wallis test followed
by the Dunn multiple-comparison test or ANOVA with
Bonferroni’s multiple-comparisons test was used, respectively.
Densitometry of immunoblots was analyzed by paired two-
tailed Student t test or Wilcoxon signed rank tests for normally
distributed and non-normally distributed data sets, respectively.
p values < 0.05 were deemed statistically significant.
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